Drug Information
Side Effects > Taclonex Topical Suspension

Taclonex Topical Suspension Side Effects

Please note - some side effects for Taclonex Topical Suspension may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).



Taclonex Topical Suspension Side Effects - for the Professional

Taclonex Topical Suspension

The most common adverse reactions (≥ 1%) are folliculitis and burning sensation of skin (6.1)



To report SUSPECTED ADVERSE REACTIONS, contact Warner Chilcott at tel:1-800-521-8813 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch



See 17 for PATIENT COUNSELING INFORMATION

Revised: 07/2008
FULL PRESCRIBING INFORMATION: CONTENTS*
* Sections or subsections omitted from the full prescribing information are not listed

1 INDICATIONS AND USAGE

1.1 Indication

1.2 Limitations of Use

2 DOSAGE AND ADMINISTRATION

2.1 Usual Dosage and Administration

3 DOSAGE FORMS AND STRENGTHS

4 CONTRAINDICATIONS

5 WARNINGS AND PRECAUTIONS

5.1 Effects on Calcium Metabolism

5.2 Effects on Endocrine System

5.3 Local Adverse Reactions with Topical Corticosteroids

5.4 Allergic Contact Dermatitis with Topical Corticosteroids

5.5 Allergic Contact Dermatitis with Topical Calcipotriene

5.6 Concomitant Skin Infections

5.7 Unevaluated Uses

5.8 Eye Exposures

5.9 Ultraviolet Light Exposures

6 ADVERSE REACTIONS

6.1 Clinical Studies Experience

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

8.3 Nursing Mothers

8.4 Pediatric Use

8.5 Geriatric Use

10 OVERDOSAGE

11 DESCRIPTION

12 CLINICAL PHARMACOLOGY

12.1 Mechanism of Action

12.2 Pharmacodynamics

12.3 Pharmacokinetics

13 NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

14 CLINICAL STUDIES

14.1 Controlled Clinical Studies

16 HOW SUPPLIED/STORAGE AND HANDLING

16.1 How Supplied

16.2 Storage

16.3 Handling

17 PATIENT COUNSELING INFORMATION

17.1 Instructions for Use

17.2 Adverse Reactions

17.3 Concomitant Use of Other Corticosteroids

17.4 Excessive Exposure to Light

Patient Information


FULL PRESCRIBING INFORMATION Top

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


MedNotes
Advertisement

(web4)